Galena Biopharma Inc. Imploded in March — Here’s Why – Motley Fool

Motley Fool
The other, more prominent drag on Galena’s shares last month was the sale of approximately 24.4 million shares of common stock alongside roughly 12.2 million shares worth of warrants with an exercise price of $2.08. The offering raised $35.4 million in

and more

…read more

Scroll to Top